Monday, May 08, 2017 9:12:03 AM
A Late Response To Post #3632
Form-4 Selling Or Insider Selling Makes No Difference. In Fact, Institutional Selling
Holds Even More Weight. Especially When They Hold A Lot Of Shares !
If Temasek Is Such A "Troubled Company", Then It Is Partly Because Of Their Bad Business Decision To Get Involved With This Company. No Wonder They Re-Evaluated Their Position, And Then Started To Sell.
And What's Even Worse, They Are Holding Shs At A Par Value Of $0.0001 Per Share. The Common Investor Just Gets Taken For A Ride, Again And Again. While The "Insiders" Take Advantage Of Them. That Little P-n-D That Happened A While Ago Is Starting To Make Even More And More Sense Now... Thanks A Lot !!!
It's Funny Though... Temasek Use To Be Viewed And Pumped As A "Big Positive", Because They Were Considered Such A Large Shareholder. And That It Must Have Meant It Was Because They Were "So Smart".
But Now... There Are Only "Excuses" As To Why They Are Selling. Excuses To Prop Up A "Failing Myth". When They Probably Realized They Just Made A Really Big Mistake ... LOL ... A 1-For-15 Reverse-Split Is Now Coming.
And Today... It Looks Like They Gave Away More Of The Company For Notes, Warrants, And A Lot Dilution... As Usual. This Was NOT A Choice. This Is What They Were FORCED To Do, Just To Hang On.
IS THAT CLOSE ENOUGH
Recent AMRSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:39 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/10/2024 02:24:29 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/10/2024 02:14:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:42:49 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/14/2023 09:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:23:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:43:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM